Adenovirus infections in immunocompetent and immunocompromised patients

T Lion - Clinical microbiology reviews, 2014 - Am Soc Microbiol
Human adenoviruses (HAdVs) are an important cause of infections in both
immunocompetent and immunocompromised individuals, and they continue to provide …

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

A Zumla, M Rao, RS Wallis, SHE Kaufmann… - The Lancet Infectious …, 2016 - thelancet.com
Despite extensive global efforts in the fight against killer infectious diseases, they still cause
one in four deaths worldwide and are important causes of long-term functional disability …

[HTML][HTML] Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation

S Prockop, E Doubrovina, S Suser… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Adoptive transfer of donor-derived EBV-specific cytotoxic T-lymphocytes
(EBV-CTLs) can eradicate EBV-associated lymphomas (EBV-PTLD) after transplantation of …

[HTML][HTML] Strategies of adoptive T-cell transfer to treat refractory viral infections post allogeneic stem cell transplantation

T Kaeuferle, R Krauss, F Blaeschke, S Willier… - Journal of hematology & …, 2019 - Springer
Background Allogeneic hematopoietic stem cell transplantation (HSCT) can expose patients
to a transient but marked immunosuppression, during which viral infections are an important …

T cells for viral infections after allogeneic hematopoietic stem cell transplant

CM Bollard, HE Heslop - Blood, The Journal of the American …, 2016 - ashpublications.org
Despite recent advances in the field of allogeneic hematopoietic stem cell transplantation
(HSCT), viral infections are still a major complication during the period of immune …

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

M Neuenhahn, J Albrecht, M Odendahl, F Schlott… - Leukemia, 2017 - nature.com
Cytomegalovirus (CMV) infection is a common, potentially life-threatening complication
following allogeneic hematopoietic stem cell transplantation (allo-HSCT). We assessed …

Virus-specific T-cell banks for'off the shelf'adoptive therapy of refractory infections

RJ O'Reilly, S Prockop, AN Hasan, G Koehne… - Bone marrow …, 2016 - nature.com
Adoptive immunotherapy with transplant donor-derived virus-specific T cells has emerged
as a potentially curative approach for the treatment of drug-refractory EBV+ lymphomas as …

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells

B Withers, E Blyth, LE Clancy, A Yong… - Blood …, 2017 - ashpublications.org
Donor-derived adoptive T-cell therapy is a safe and effective treatment of viral infection
posttransplant, but it is limited by donor serostatus and availability and by its personalized …

[HTML][HTML] Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation

M Uhlin, H Wikell, M Sundin, O Blennow… - …, 2014 - ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplantation is a successful treatment for hematologic
malignancies and a variety of genetic and metabolic disorders. In the period following stem …

[HTML][HTML] American Society for Transplantation and Cellular Therapy Series:# 4-Cytomegalovirus treatment and management of resistant or refractory infections after …

MK Yong, TL Shigle, YJ Kim, PA Carpenter… - … and Cellular Therapy, 2021 - Elsevier
Abstract The Practice Guidelines Committee of the American Society of Transplantation and
Cellular Therapy (ASTCT) partnered with its Transpl. Infect. Dis. Special Interest Group (TID …